{"id":33,"date":"2026-11-06T09:06:23","date_gmt":"2026-11-06T09:06:23","guid":{"rendered":"https:\/\/healthcare.hibisports.com\/?p=33"},"modified":"2026-11-06T09:06:23","modified_gmt":"2026-11-06T09:06:23","slug":"whats-new-in-obesity-treatment","status":"publish","type":"post","link":"https:\/\/healthcare.hibisports.com\/?p=33","title":{"rendered":"What\u2019s New in Obesity Treatment?"},"content":{"rendered":"
\n

Ozempic and Mounjaro are drugs that can be used to treat type 2 diabetes. But you\u2019ve likely heard of them because they\u2019re all over the news for weight loss.\n<\/p>\n

<\/div>\n

Ozempic, Mounjaro, Wegovy, Zepbound, and Foundayo are in a newer class of drugs called GLP-1 agonists. These medications, available as injections or pills, are currently the most effective diabetes and weight management medications available, leading to an average weight loss of 6% to 20%, depending on the drug.\n<\/p>\n

<\/div>\n

Research shows that some of these drugs also lower the risk of heart and kidney disease. They work quite differently from most of the weight loss drugs that have come before them by suppressing appetite, slowing digestion, and making patients feel full faster.\n<\/p>\n

<\/div>\n
\n
\n
\n\"An
\n